The Department of Health and Human Services (“HHS”) recently proposed a policy that would require all new vaccines to undergo placebo-controlled clinical trials prior to FDA approval. The proposal, while controversial, is rooted in calls for greater methodological rigor and transparency in vaccine research—two concerns of increasing interest to both health care practitioners and legal…